Zyla Health Bags $4 Mn To Boost Personalised Offerings For Chronic Patients

Business-to-business (B2B) healthtech startup Zyla Health has raised $4 Mn (INR 33 Cr) as a part of its Series A funding exercise led by Exfinity Venture Partners.

The funding round also saw participation from Sony Innovation Fund, Venture Catalysts and Aureolis Ventures.

Gurugram-based Zyla Health will deploy the fresh proceeds to scale up growth across its three verticals – insurance, corporates and pharmaceuticals.

Founded in 2017 by Khushboo Aggarwal and Tanmay Patil, Zyla provides personalised care to chronic patients, supported by its in-house care team. The startup works with insurers to reduce their claims, corporates to reduce insurance premiums, and pharmaceutical companies to improve medication outcomes as well as adherence for drug users.

It counts the likes of Max Life Insurance, HDFC Ergo, Pfizer, Zydus, IBM, DHL, Godrej and GEP among its clients. 

“Our vision for healthcare in India is an ecosystem that puts patients at the centre with every stakeholder working towards driving better health outcomes for the patient. We will give the mission everything we have,” said Aggarwal.

She added that the startup has logged 300% year-on-year growth and 100% retention of key B2B accounts in the last one year.  

India’s healthcare space has been gaining investors’ traction for quite some time now. In September, healthcare startup QubeHealth secured an undisclosed amount of funding to develop a runway of up to two years and enable it to prepare for the upcoming Series A round. 

Another health assessment startup Karma Primary Healthcare secured an undisclosed amount of Series A funding round to bridge the prevailing gaps in the rural healthcare sector by increasing awareness, promoting preventive healthcare, improving supply chain efficiencies, and improving curative service delivery. 

According to Inc42’s analysis, the Indian healthtech startups have raised over $6.4 Bn funding since 2014, and the market size is expected to grow to $10.6 Bn by 2025.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.